Keros Therapeutics, Inc. - KROS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | — | P | A | 1,000.0 | 10.61 | 10,610.0 | 18,592.0 | View | |
| Jul 06, 2026 | — | A | A | 14,870.0 | 0.0 | 0.0 | 14,870.0 | View | |
| Jul 06, 2026 | — | A | A | 13,786.0 | 0.0 | 0.0 | 13,786.0 | View | |
| Jun 17, 2026 | — | P | A | 1,000.0 | 10.19 | 10,190.0 | 17,592.0 | View | |
| Jun 15, 2026 | — | S | D | 550.0 | 10.04 | 5,522.0 | 12,665.0 | View | |
| Jun 08, 2026 | — | S | D | 2,625.0 | 10.73 | 28,166.25 | 10,958.0 | View | |
| Jun 08, 2026 | — | S | D | 2,625.0 | 10.73 | 28,166.25 | 9,767.0 | View | |
| Jun 05, 2026 | — | A | A | 7,433.0 | 0.0 | 0.0 | 7,433.0 | View | |
| Jun 05, 2026 | — | A | A | 7,142.0 | 0.0 | 0.0 | 12,392.0 | View | |
| Jun 05, 2026 | — | S | D | 2,625.0 | 10.72 | 28,140.0 | 9,767.0 | View | |
| Jun 05, 2026 | — | A | A | 7,433.0 | 0.0 | 0.0 | 7,433.0 | View | |
| Jun 05, 2026 | — | A | A | 7,142.0 | 0.0 | 0.0 | 12,392.0 | View | |
| Jun 05, 2026 | — | A | A | 7,433.0 | 0.0 | 0.0 | 7,433.0 | View | |
| Jun 05, 2026 | — | A | A | 7,142.0 | 0.0 | 0.0 | 12,392.0 | View | |
| Jun 05, 2026 | — | A | A | 7,433.0 | 0.0 | 0.0 | 7,433.0 | View | |
| Jun 05, 2026 | — | A | A | 7,142.0 | 0.0 | 0.0 | 16,592.0 | View | |
| Jun 05, 2026 | — | A | A | 7,433.0 | 0.0 | 0.0 | 7,433.0 | View | |
| Jun 05, 2026 | — | A | A | 7,142.0 | 0.0 | 0.0 | 13,583.0 | View | |
| May 19, 2026 | — | P | A | 1,000.0 | 10.58 | 10,580.0 | 9,450.0 | View | |
| Apr 17, 2026 | — | P | A | 1,000.0 | 11.7 | 11,700.0 | 8,450.0 | View | |
| Apr 06, 2026 | CHIEF EXECUTIVE OFFICER | M | D | 55,000.0 | 0.0 | 0.0 | 197,444.0 | View | |
| Apr 06, 2026 | CHIEF EXECUTIVE OFFICER | M | A | 55,000.0 | 0.3 | 16,500.0 | 440,708.0 | View | |
| Mar 27, 2026 | Chief Legal Officer | A | A | 80,000.0 | 0.0 | 0.0 | 80,000.0 | View | |
| Mar 11, 2026 | — | A | A | 14,788.0 | 0.0 | 0.0 | 14,788.0 | View | |
| Mar 11, 2026 | — | A | A | 13,215.0 | 0.0 | 0.0 | 13,215.0 | View | |
| Mar 11, 2026 | — | P | A | 2,000.0 | 11.21 | 22,420.0 | 7,450.0 | View | |
| Feb 26, 2026 | Chief Legal Officer | A | A | 80,000.0 | 0.0 | 0.0 | 80,000.0 | View | |
| Feb 26, 2026 | CHIEF FINANCIAL OFFICER | A | A | 60,000.0 | 0.0 | 0.0 | 60,000.0 | View | |
| Feb 26, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Feb 26, 2026 | CHIEF EXECUTIVE OFFICER | A | A | 217,000.0 | 0.0 | 0.0 | 217,000.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Feb 20, 2026 | CHIEF FINANCIAL OFFICER | S | D | 4,739.0 | 16.35 | 77,482.65 | 39,261.0 | View | |
| Feb 20, 2026 | SVP, General Counsel | S | D | 4,745.0 | 16.35 | 77,580.75 | 39,755.0 | View | |
| Feb 20, 2026 | Chief Science Officer | S | D | 3,873.0 | 16.35 | 63,323.55 | 31,127.0 | View | |
| Feb 20, 2026 | CHIEF EXECUTIVE OFFICER | S | D | 7,015.0 | 16.17 | 113,432.55 | 385,708.0 | View |